Jun 24, 2026 04:05PM
Jun 24, 2026 04:05PM
Jun 4, 2026 08:00AM
May 15, 2026 06:00AM
Apr 15, 2026 06:06AM
Apr 15, 2026 06:05AM
Mar 27, 2026 09:49AM William Blair on ARS Pharmaceuticals Inc (SPRY): FDA label update 'viewed positively'
Mar 27, 2026 08:00AM
Mar 27, 2026 08:00AM
Mar 9, 2026 06:00AM
Mar 2, 2026 06:37AM
Feb 10, 2026 08:00AM
Feb 2, 2026 08:00AM
Feb 2, 2026 08:00AM EURneffy® 1 mg (adrenaline nasal spray) Recommended for Approval in the EU for Emergency Treatment of Type 1 Allergic Reactions, including Anaphylaxis in Children Weighing ≥15 kg to <30 kg
Jan 21, 2026 08:00AM
Dec 29, 2025 08:00AM
Dec 29, 2025 08:00AM
Nov 10, 2025 06:00AM
Nov 4, 2025 08:00AM
Nov 3, 2025 02:23PM
Nov 3, 2025 02:23PM UPDATE -- ARS Pharma to Present Real-World Data on Intranasal Epinephrine at 2025 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
Nov 3, 2025 07:45AM
Nov 3, 2025 07:45AM
Oct 8, 2025 08:00AM
Oct 8, 2025 08:00AM
Sep 29, 2025 04:06PM
Sep 29, 2025 04:05PM
Sep 19, 2025 08:01AM ARS Pharmaceuticals gains Japan approval for needle-free epinephrine spray
Sep 19, 2025 08:00AM
Sep 8, 2025 08:00AM
Aug 13, 2025 07:00AM
Jul 18, 2025 09:26AM
Jul 18, 2025 09:25AM
May 14, 2025 07:00AM
May 7, 2025 08:00AM ARS Pharmaceuticals’ neffy® (epinephrine nasal spray) 1 mg is Now Available in the United States for Type I Allergic Reactions, including Anaphylaxis, in Pediatric Patients Weighing 15 to < 30 Kilo
May 7, 2025 08:00AM
May 2, 2025 08:00AM
Mar 20, 2025 07:00AM
Mar 5, 2025 04:11PM
Mar 5, 2025 04:10PM
Mar 5, 2025 04:10PM
Feb 20, 2025 07:02PM ARS Pharmaceuticals Announces OptumRx, Cigna Healthcare and Navitus Health Systems Add neffy® (Epinephrine Nasal Spray) to National Formularies, Further Expanding Coverage for Patients
Feb 18, 2025 08:00AM
Jan 21, 2025 08:00AM
Jan 13, 2025 08:00AM
Jan 6, 2025 08:10AM
Jan 6, 2025 08:00AM
Dec 19, 2024 05:25PM
Dec 12, 2024 02:33PM ARS Pharmaceuticals (SPRY) Announces Filings for Approval of neffy in China, Japan and Australia
Dec 12, 2024 02:32PM

324,165 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All